Hyponatremia - PowerPoint PPT Presentation

1 / 51
About This Presentation
Title:

Hyponatremia

Description:

Hyponatremia Hyponatremia Chronic Asymptomatic Symptomatic Long term management Treat etiology Water restriction Demeclocycline Urea V2 receptor antagonist Some ... – PowerPoint PPT presentation

Number of Views:2674
Avg rating:5.0/5.0
Slides: 52
Provided by: Rak58
Category:

less

Transcript and Presenter's Notes

Title: Hyponatremia


1
Hyponatremia
2
Why hyponatremia important ?
  • Common electrolyte abnormality- inpatient and
    outpatient
  • Up to 15 of inpatients 1
  • Acute-
  • 8.4 in childen
  • 55 in adults
  • Chronic
  • 14-27
  • 1. Baylis PH. Int J Biochem Cell Biol.
    2003351495-1499.

3
  • Important cause of mortality
  • Mortality more if hyponatremia develops after
    hospitalisation
  • Increased duration of hospital stay
  • Increased mortality continues even after
    discharge
  • Even mild hyponatremia though till now considered
    benign is associated with osteoporosis and
    fractures
  • Adrogué HJ. Am J Nephrol. 200525240-249
  • Gill ,clin endocrino 2006
  • Clayton ,QJM 2006
  • European Jr of Endocrinology,2010

4
Definition of Hyponatremia
  • Normal serum sodium level
  • 135 145mEq/L
  • Hyponatremia is defined as a serum sodium level
    less than 135mEq/L
  • Severe - serum Na lt 120mEq/L

5
symptoms
6
Clinical Manifestations
  • Hyponatremia not a disease but a manifestation of
    a variety of disorders.
  • Clinical symptoms
  • hyponatremia itself
  • Disease causing hyponatremia
  • recognition of hyponatremia incidental.

7
Pathogenesis
Acute Low serum Na More Na in brain Water
enters brain cells Cerebral oedema Chronic Adap
tation
8
Symptoms depend on magnitude of the hyponatremia
rapidity of its development.
Asymptomatic GI sym Headache Lethargy Confusion O
btundation
S Na gt 125 mmol/L or Gradual onset

Stupor Seizures Coma Rhabdomyolysis Brain stem
compressiom Pulm oedema
Na level lt120mEq/L or Rapid decrease(lt48hr)
9
Symptoms signs
  • Gait disturbances
  • Fractures
  • reduction in total hip bone mineral density of
    0.037 g/cm2 for every 1 mmol/l drop in plasma
    sodium concentration.
  • European Jr Endocrinology 2010

10
Etiology -Hyponatremia
?
Hyperlipidemia Hyperproteinemia
?
?
?
?
Hyperglycemia Mannitol
CHF NS Cirrhosis
CRF
Salt wasting dz RTA Diuretics Cerebral salt
wasting
GI loss 3rd space loss
SIADH GC def Hypothyroid Exercise ind Psychogenic
11
Determine if true Hyponatremia?
  • IA Pseudohyponatremia/Normal plasma osmolality
  • (275-295)
  • Hyperlipidemia - ion-specific electrodes avoid
    this
  • Hyperproteinemia-Multiple myeloma
  • IB Increased plasma osmolality /Translocational/re
    distributive
  • (osmo gt 295)
  • Hyperglycemia 1.6 mEq/L for every 100 mg/dL
    glucose)
  • Mannitol
  • II. Hypoosmolal hyponatremia (serum
    osmolalitylt275mOsm/kg)

12
How to detect Pseudohypo? check pl osmolality.
  • Measured by osmometer
  • Calculated Pl osmolality
  • 2xNa(mEq/L) serum glucose(mg/dL)/18
    BUN (mg/dL)/2.8
  • True hyponatremia Both are equal or lt 10 mosm
    diff Pseudo Calculated OSM lt
    Measured OSM

If osmolality not available check routine
biochemistry
13
2 stepcheck volume status
Euvolemic
Hypervolemic
Hypovolemic
14
Hypovolemic- Low CVP Responds to NS
  • Low urine Na(lt20 mmol/l)
  • High urine Na gt20 mmol/l
  • Non renal
  • Volume Depletion
  • GI, lung or skin losses -burns
  • Third space sequestration
  • CSW
  • Excess water intake
  • Renal
  • Salt wasting nephropathy
  • Mineralocorticoid deficiency-high K
  • Osmotic diuresis-KB
  • Cerebral salt wasting

Step 3 Check renal or non renal Urine Na
15
Diuretics
  • Loop Diuretics
  • Urine excreted 1/2 NS
  • Lose gt water than thiazides
  • Reason for hypoNa
  • Impair generation of medullary hypertonicity
  • Thiazides
  • Urine excreted- NS
  • Lose more salt than loop
  • Reason for hypoNa
  • Interfere with urine dilution
  • Common in elderly females
  • Occurs within 2-4 weeks
  • Discontinue diuretics

16
Cerebral Salt Wasting
  • Causes Head injury, surgery, tumors, Infections
  • Signs/symptoms
  • Polyuria, Dehydration/hypovolemia/Hypotension
  • High urine Na gt 20 mmol/L
  • Pathogenesis
  • ? renal Na loss d/t plasma ANP, BNP ?
  • Volume depletion could be protective for ICP
  • Treatment
  • Volume replacement - large volumes of NS
  • Oral Na supplementation for a period of time
  • Berendes Lancet 1997, Isotani Stroke
    1994, Wijdicks Stroke 1991
  • Mather J Neuro Nsurg Psych 1981 Wijdicks Ann
    Neuro 1985

17
TreatmentHypovolemic hyponatremia
  • Isotonic saline
  • ? Restoration of euvolemia removes the
    hemodynamic stimulus for AVP release
  • ? Excretion of the excess free water

18
Hypervolemic
Euvolemic
Hypovolemic
19
Hypervolemic -High CVP Increased total
body water that exceeds the increase in total
body Na
  • High urine Na gt20 mmol/l
  • Low urine Na lt20 mmol/l
  • CHF
  • Cirrhosis with ascites
  • Nephrotic syndrome
  • Advanced renal failure

Step 3 Check urine Na
20
TreatmentHypervolemic hyponatremia
  • Restriction of Na and water intake
  • Promotion of water loss in excess of Na
  • Vasopressin antagonists approved for use
  • Correction of underlying disorder

21
Hypervolemic
Euvolemic
Hypovolemic
22
Euvolemic Normal CVP
  • Normal sodium stores (N ECF) total body excess
    of free water.
  • SIADH/Reset osmostat
  • Primary polydipsia
  • Hypothyroidism
  • Glucocorticoid deficiency
  • Exercise induced
  • Beer potomania
  • Post op

Step 3 All have high urine Na U osm lt100 in PP,
BP
23
SIADH (Bartters Criteria)60 of all euvolemic
hyponatremia
  • F
  • Essential criteria
  • Hyponatremia
  • pl osmlt275
  • Euvolemia clinical
  • u osmolality gt 200 mOsm/kg
  • N renal, cardiac, hepatic, adrenal, pituitary,
    thyroid
  • No H/o antidiuretic drugs
  • No emotional or physical stress
  • Urinary sodium gt 20 mEq/l
  • Cr N, N ABG, K handling
  • Supplemental features
  • uric acidlt4
  • BUNlt10
  • failure to correct hypoNa after NS infusion
  • correction of hypoNa after fluid restriction
  • ? S ADH

Step 4 Check urine osmolality K/Cr/ Cr/Urea/uric
acid T3/T4/TSH Cortisol CT as needed
U SP gravity can be used if u osm not possible, U
osm 100 u sp gr 1.005
a
24
Disorders associated with SIADH
  • CNS-ADH secr
  • Encephalitis /Meningitis , trauma
  • Brain abscess/Brain tumors
  • GBS/Acute intermittent porphyria
  • Subarachnoid/subdural hematoma
  • Cerebellar and cerebral atrophy
  • Cavernous sinus thrombosis
  • Neonatal hypoxia
  • Hydrocephalus
  • Delirium tremens
  • CVA, Acute psychosis
  • Peripheral neuropathy
  • Multiple sclerosis
  • Pulmonary
  • Pulmonary abscess
  • Tuberculosis
  • Aspergillosis
  • Positive-pressure breathing
  • Asthma
  • Pneumothorax
  • Cystic fibrosis
  • Lung cancers

Cancers Small cell carcinoma of the
lung Carcinoma of the duodenum Carcinoma of the
pancreas Thymoma Lymphoma Ewings
sarcoma Mesothelioma Carcinoma of the
bladder Prostatic carcinoma Olfactory
neuroblastoma
PULMONARY
CANCERS
CNS
25
SIADH CSW
CNS problem yes yes
Urine Na High (renal) High (renal)
Urine osm High gt100 mosm/kg lt 100 mosm/kg
Urine Output decreased polyuric
CVP High (Euvolemic) Low (Hypovolemic)
BUN N or ?BUN ?BUN
26
DRUGS
  • Antidiuretic hormones
  • Vasopressin,oxytocin
  • Diuretics
  • Thiazides,furosemide,
  • CNS-active drugs
  • Vincristine,carbamazepine,
  • Psychotropic drugs
  • Inhibitors of prostaglandin
  • Chlorpropamide, Salicylates,
  • Acetaminophen, NSAIDS,COX 2 I
  • Others
  • Clofibrate,Cyclophosphamide,
  • Somatostatin

27
Primary Polydipsia
  • Psychiatric disorder, ? thirst with
    antipsychotics
  • Hypothalamic lesions
  • No hyponatremia unless intake gt10-15 L/d, or
    acute 3-4 L water load
  • Urine osm below 100
  • Rx Restrict free water classically rapid
    correction

28
Reset osmostat
  • Can excrete water load (10 to 15 mL/kg given
    orally or intravenously). -excrete more than 80
    percent within 4 hours
  • Mild hyponatremia
  • No treatment needed

29
Beer protomaniaLow Dietary Solute Intake
  • Elderly, malnourished (tea and toast diets)
    -poor in solutes (Na/K)
  • Beer drinkers (high water intake, low protein)
  • Pathogenesis
  • Minimum urine osmolarity- 60 mosm/l
  • At least 600-900 msom/kg/d solute load needed to
    excrete water gt4 l
  • Beer protomania- daily solute excretion lt 250
    mosmol /kg, hence maximum urine output can be lt4
    L day ,if more water ingested -hyponatremia
  • Urine appears dilute (osm oflt 100)
  • Rx NS, increased dietary solute

30
Exercise associated hyponatremia (EAH)
  • Clinical features
  • May be severe cerebral edema, non cardiac PE
  • Pathogenesis
  • H2O excess impaired renal H2O excretion
  • Nonosmolar AVP release esp if water in gtout
  • Treatment
  • Limit water to 400-800 ml/h drink only when
    thirsty
  • No role of NS, 3 Nacl if severe

  • JCEM
    2008932072-78

31
Investigations
  • History volume status
  • Serum Osmolality
  • Urine Osmolality/sp gr
  • Urine Na
  • S Cr/urea/K
  • T3/T4/TSH
  • CXR
  • CT Scan

32
Hyponatremia
Step1 S osmolality
N 275-295 Hyperlipidemia Hyperproteinemia
Lowlt275 True
Highgt295 Hyperglycemia Mannitol
Step 2 Volume
High
Hypovolemic
Euvolemia
Step3 Urine Na
Step 3 Urine Na
Step 4 U Osm/TSH/GC
lt 20 mmol/l CHF NS Cirrhosis
gt20 mmol/l CRF
Renal Salt wasting dz RTA Diuretics Cerebral salt
wasting
Extra renal GI loss 3rd space loss
SIADH GC def Hypothyroid Exercise ind Psychogenic
33
Treatment Euvolemic Hyponatremia
34
Hyponatremia
Asymptomatic
Symptomatic
Chronic
Acute lt48 hrs
Chronicgt48 hrs
Some immediate correction Hypertonic saline
Furosemide Change to water restriction Frequent
serum urine electrolytes Do not exceed 12
meq/l/d
No immediate Correction needed
Emergency Hypertonic saline furosemide
Long term management Treat etiology Water
restriction Demeclocycline Urea V2 receptor
antagonist
Thurman et al,Therapy in nephrology and
Hypertension,Saunders 2003
35
Therapeutic Strategy Euvolemic hyponatremia
  • Treatment varies with
  • Presence or Absence of Symptoms
  • Duration
  • Magnitude of Hyponatremia
  • Risk for neurological dz- young, females,
    elderly,menstruation

36
Acute/Severe/symptomatic hyponatremia
37
  • Rate of correction of
    hyponatremia
  • Acute
  • severe (S Na lt115mmol/L)
  • symptomatic
  • Hypertonic (3 NaCl)
  • 0.5 mmol/l/hr or 12 mmol/l/day
  • Stop
  • if convulsions subside
  • if S Na 120 mEq/L


  • Kumar S, Berl T. The Lancet 1998 352 220-8


  • Adrogue HJ, Madias NE. NEJM 2000 342 1581-9

38
Fluids for correction
  • Ringers 130 mEq/L
  • 0.45NS 77 mEq/L
  • 3 NaCl- 513 meq/L
  • 0.9 NaCl- 154 meq/L

39
Total correction in 12 hrs 6 mmol
  • Volume of infusate needed
  • B Wt X 0.6 X Desired increment in Na
    (120-114)
  • Infusate Na X 1.5
  • 50 kg
  • 50X 0.6x6 0.23 litre or 230 ml
  • 513X1.5
  • 230 ml in 12 hours
  • 19 ml/hr

40
Symptomatic/chronichyponatremiaGradual
correction
41
Chronic symptomaticgt48 hrs
  • 3 NaCL
  • lt 0.5 to 1.0mmol/L per h
  • (lt10 to 12mmol/L over first 24h)
  • Water restriction
  • Chronic asymptomatic gt 48 hours
  • No immediate correction
  • Water restriction

42
Long term management Euvolemic
hyponatremia
  • Water restriction
  • Free water restriction ,¾ maintenance (1 L/d)
  • Clozapine -schizophrenic patients with compulsive
    water drinking
  • Pharmacological agents (Long-term)
  • Demeclocycline 300 - 600 mg bd
  • Urea 15-60 gm/d
  • Lithium
  • V2 receptor antagonist- Aquaretics

43
AVP Receptor antagonists
  • Mechanism of action
  • Bind to the V2 receptors in renal collecting
    tubules/ducts
  • Vasopressin antagonist
  • Uses
  • Euvolemic/ hypervolemic hypo Na Contraindicated
    in hypovolemia
  • Chronic hyponatremia
  • not in acute hyponatremia or in patients with
    sNa lt 115 mmol/L
  • as slow aquaresis
  • Adverse effects
  • Thirst dry mouth

SALT NEJM 2006
44
Vasopressin Receptor Location Functions (KI
2006)
45
Vasopressin Receptor Antagonists
Tol-vaptan Lixi-Vaptan Sata-vaptan Coni-vaptan
Receptor V2 V2 V2 V1a/V2
Route of administration Oral Oral Oral IV
Urine Volume
UOSM
24 h Na excretion No ? No ? low Dose High Dose No ? No ?
SALT I and SALT II Trials.
46
CI
  • Concomitant use of vaptan and potent CYP3A4
    inhibitors such as ketoconazole, itraconazole,
    clarithromycin, ritonavir, or indinavir is
    contraindicated

47
Central Pontine MyelinolysisOsmotic demyelination
  • Pathogenesis
  • rapid correction / overcorrection of ch
    hyponatremia.  
  • hypoxic encephalopathy / complication of therapy
  • Prevention
  • Adequate oxygenation
  • Gradual increase in serum sodium level to 120-125
    mEq/L.
  • Symptoms
  • Dysarthria, dysphagia, seizures, altered mental
    status, quadriparesis, hypotension ,locked in
    syndrome, extrapontine
  • Begin 1-3 days after correction of S Na
  • Irreversible , devastating
  • MRI diagnostic lt 24 h
  • Risk factors- Hypokalemia, females,alcoholism,
    liver transplant
  • Treatment- Relowering S Na - hypotonic fluids,
    Desmopressin

48
Summarising
49
Hyponatremia
S osmolality
N 275-295 Hyperlipidemia Hyperproteinemia
Lowlt275 True
Highgt295 Hyperglycemia Mannitol
Volume
High
Hypovolemic
Euvolemia
Urine Na
Urine Na
lt 20 mmol/l Extrarenal CHF NS Cirrhosis
Urine Osm, S Cr,Ur,TSH
gt20 mmol/l Renal CRF
Renal Salt wasting dz Diuretics Cerebral salt
wasting
Extra renal GI loss 3rd space loss
SIADH GC def Hypothyroid Exercise ind Psychogenic
50
Hyponatremia
Asymptomatic
Symptomatic
Acute lt48 hrs
No immediate Correction needed
Emergency
Long term management
Hypertonic saline
Go slow
51
Take home message
  • Hyponatremia a common, life theatening problem
  • Step wise evaluation important
  • Inappropriate treatment Worse than disease
  • Practising is the best way of learning!!!

52
Hope some pieces of puzzle are in place !!
Write a Comment
User Comments (0)
About PowerShow.com